FDA Proposes Permanent Ban on Compounded Semaglutide and Tirzepatide On April 30, 2026, the FDA proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, effectively ending large-scale compounding of GLP-1 drugs
Scalp Serum: Orgainc Aloe Barbadensis Leaf Juice, Stinging Nettle Hydrosol, Glycerin, Hydrolized Hyaluronic Acid, Pentylene Glycol, Caffeine, Glyciene, Soy Peptide, Silica, L-Methionine, Pyridoxine, Glutamic Acid, Copper Peptide(GHK-cu), Vitamin B12, Melatonin, Biotin, Centella Asiatica Extract, Acetyl Hexapeptide-8, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-5, Allantoin, Pantothenic Acid, Hydrolyzed Keratin, Saw Palmetto, L-Arginine, Vitis Vinifera Fruit Cell Extract (Grape Stem Cell ), Myristoyl Pentapeptide-17, Ethyl Ascorbic Acid, Niacin, Zinc, Lactobacillus, Bourdock Extract, Catalase, Sodium Chloride, Disodium DHA, Methylsulfonylmethane, Propanedil, Lactic Acid, Ethylhexylglycerin
Other languages Deutsch (PDF) HTML Nederlands (PDF) HTML Franais (PDF) HTML Italiano (PDF) HTML Espaol (PDF) HTML FAQs What is DSIP used for in research
They also ship internationally to the United Kingdom and across much of Europe